Top UK stocks with healthy cash flows and dividend yields
Three promising UK stocks according to Alan Dobbie, co-manager, Rathbone Income Fund

When looking for stocks to buy we concentrate on how much cash they make and how much we’re paying to put them in our portfolio. We appraise cash flow rather than accounting profit because it represents a return more secure than promises by customers to pay later. It is also harder for companies to manipulate.
Businesses with healthy cash flow have the flexibility to repay their debts when they come due, reinvest in their businesses to create future profits, and pay dividends to shareholders. And as for valuation, the price you pay is one of the main determinants of your long-term returns.
While the past decade has not been kind to the UK stock market, we remain enthused about its prospects. Valuations are highly attractive, especially relative to other markets, and the country is still home to many high-quality businesses capable of producing good returns and rising dividends. The following are three companies we own that fit our key criteria and offer attractive and growing dividends.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Three UK stocks to energise your portfolio
National Grid (LSE: NG) was once regarded as a dull but worthy high-yielder. Now the owner of energy networks in the UK and north-eastern US is also something of a growth stock. The company has announced an extraordinary £60 billion investment plan to upgrade its infrastructure to cope with the power system’s shift from fossil fuels to renewable generation.
With thousands of miles of both offshore and onshore cables to be laid in the UK alone, the challenge is great. However, the prize of set, regulated returns on an asset base growing at 10% each year is highly attractive. Importantly, with a prospective dividend yield of 4.8%, rising with inflation, income investors haven’t been forgotten as the UK rushes towards “clean power by 2030”.
UK food retail is another area that rarely sets pulses racing, but we believe that the competitive position of the UK’s biggest supermarket, Tesco (LSE: TSCO), is better than it has been for some time. Rivals Asda and Wm Morrison, saddled with debt by their private equity owners, have been bleeding market share in recent years.
Similarly, the once formidable German discounters, Aldi and Lidl, are now more focused on profitability than gaining market share and opening new stores.
In addition, with over 23 million UK households (82%) in possession of a Tesco Clubcard, the company has incredible insight into consumer spending habits. In time, this should offer a new avenue for improving profit margins. While the surprise increase in employment costs announced in the Budget is clearly unhelpful for bricks-and-mortar retailers, we don’t think it will destabilise the firm’s strong fundamentals.
Assura (LSE: AGR), which owns and develops GP surgeries and private hospitals, is on the front line when it comes to delivering the much-needed upgrade to the UK’s healthcare estate. The Darzi Report into the state of the NHS noted that “the primary care estate is plainly not fit for purpose”, with 20% of GP surgeries predating the NHS itself, and too little of the budget being spent in the community. These findings play neatly into Assura’s plan to develop modern, purpose-built, community-based, primary-care facilities.
Recognising the problem isn’t the same as delivering the solution. More political willpower and firepower may be needed. However, demographic headwinds mean the challenges confronting the NHS are unlikely to diminish.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
'It’s time to buy British equities'
Opinion There is no better place to start investing in UK equities than with two of MoneyWeek’s favourite investment trusts, says Max King
-
How to cash in on overlooked British bargains offering both income and growth
Opinion Sue Noffke, manager of the Schroder Income Growth Fund, selects three UK stocks where she’d put her money
-
Beazley: a compelling specialist insurer
The insurer Beazley is unusually profitable at present, and that looks set to continue. The stock is also a valuable portfolio diversifier, says Jamie Ward